Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Decision Making and IL28B[original query] |
---|
IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies. The American journal of gastroenterology 2011 Jan 106 (1): 38-45. Clark Paul J, Thompson Alex J, McHutchison John |
Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay. Antiviral research 2012 Apr 94 (1): 54-6. Li Wei, Zeng Yanli, Wang Junjie, Zhou Bin, Zhang Jian, Zhang Hao, Li Jingtao, Wu Yingsong, Hamoudi Rifat, Zhou Yuanpi |
Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC medicine 2013 11 (1): 6. Jiménez-Sousa María A, Fernández-Rodríguez Amanda, Guzmán-Fulgencio María, García-Álvarez Mónica, Resino Salvad |
No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients. Clinical and molecular hepatology 2014 Jun 20 (2): 177-84. Heo Nae-Yun, Lim Young-Suk, Lee Woochang, Oh Minkyung, An Jiyun, Lee Danbi, Shim Ju Hyun, Kim Kang Mo, Lee Han Chu, Lee Yung Sang, Suh Dong J |
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection. Journal of hepatology 2014 Aug 61 (2): 235-41. Eslam Mohammed, Leung Reynold, Romero-Gomez Manuel, Mangia Alessandra, Irving William L, Sheridan David, Spengler Ulrich, Mollison Lindsay, Cheng Wendy, Bugianesi Elisabetta, McLeod Duncan, Zaitoun Abed M, Attino Vito, Goeltz Diane, Nattermann Jacob, Douglas Mark, Booth David R, George Jacob, Ahlenstiel Go |
Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients. International journal of molecular sciences 2015 16 (9): 22223-42. Enache Elena L, Sin Anca, Bancu Ligia, Ramière Christophe, Diaz Olivier, André Patrice, Enache Liviu |
Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4. Cytokine 2015 Oct 75 (2): 349-55. Rady Normeen Hany, Darwish Rania Kamal, Mogahed Engy Adel, Mandour Iman Atef, Abo Youssef Hazem, Sharaf Sahar Abdel Atty, El-Karaksy Hanaa Mosta |
Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2015 Apr 123 (4): 342-9. Imran Muhammad, Manzoor Sobia, Azam Sikandar, Resham Sale |
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study. PloS one 2015 10 (12): e0145105. About Frédégonde, Oudot-Mellakh Tiphaine, Niay Jonathan, Rabiéga Pascaline, Pedergnana Vincent, Duffy Darragh, Sultanik Philippe, Cagnot Carole, Carrat Fabrice, Marcellin Patrick, Zoulim Fabien, Larrey Dominique, Hézode Christophe, Fontaine Hélène, Bronowicki Jean-Pierre, Pol Stanislas, Albert Matthew L, Theodorou Ioannis, Cobat Aurélie, Abel Laurent, |
Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 Sep 65 (6): 999-1005. Hashem Mohamed, Jhaveri Ravi, Saleh Doa'a A, Sharaf Sahar A, El-Mougy Fatma, Abdelsalam Lobna, Shardell Michelle D, El-Ghazaly Hesham, El-Kamary Samer |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: